About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,034 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,034 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2481-2500 of 8,034 trials

RecruitingCarfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung CancerThis phase I trial tests the safety, side effects, and best dose of carfilzomib in combination with sotorasib in treating patients with KRAS G12C-mutated non-small cell lung…NCT06249282·Duarte, California and 1 other CompletedTarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung CancerThe goal of this clinical research study is to learn whether Tarceva (erlotinib hydrochloride), when given in addition to whole brain radiation therapy, is better to treat brain…NCT00871923·Tucson, Arizona and 1 other CompletedA Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsProtocol B8011001 is a Phase 1, open-label, multi-center, multiple-dose, dose escalation and expansion, safety, pharmacokinetics (PK), and pharmacodynamics (PD) study of…NCT02573259·Los Angeles, California and 66 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedComparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancersurgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung CancerMany recent studies have shown that surgical trauma will result in an immunosuppressive state.NCT05070026·Shenyang, Liaoning

UnknownK-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C MutationThe goal of this interventional study is to learn about the combination of sotorasib and stereotactic radiation therapy (SBRT) in patients with metastatic non-small cell lung…NCT06127940·Stockholm, Solna

Not yet recruitingRadiation-induced Toxicity of the HeartLate side effects in radio(chemo)therapy \[R(CH)T\] pose a critical limitation to patients' overall survival and quality of life.NCT06986291·Dresden, Germany

CompletedA Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung CancerThis 2 arm study will evaluate the efficacy and safety of Avastin + gemcitabine, and Avastin + gemcitabine + attenuated doses of cisplatin, as first line treatment in elderly…NCT01077713·Rionero in Vulture, Basilicate and 25 others

WithdrawnA Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)This phase I/II, multi-centered, non-randomized trial is designed to determine a safe dose of PT-523 for subjects, and to make preliminary evaluations on the activity of PT-523 as…NCT00112060·Miami, Florida and 12 others

TerminatedA Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung CancerDetermine whether viagenpumatucel-L combined with low-dose cyclophosphamide prolongs survival in patients with NSCLC who failed 2 or 3 prior lines of therapy for incurable or…NCT02117024·Rogers, Arkansas and 15 others

TerminatedLenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung CancerThe purpose of this study is to investigate the safety and efficacy of maintenance therapy with daily low dose lenalidomide in patients with stage IIIB/IV non-small cell lung…NCT02018523·Houston, Texas

CompletedS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy…NCT02728596·Jonesboro, Arkansas and 159 others

CompletedStereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung CancerIt is apparent that local control for Non-small Cell Lung Cancer (NSCLC) remains a significant problem.NCT01657617·Lexington, Kentucky

Not yet recruitingTesting Repeat Radiation Therapy for Recurrent Non-small Cell Lung CancerThis phase II trial compares repeat radiation therapy (RT) to standard drug treatment alone in treating patients with stage II-III non-small cell lung cancer (NSCLC) that has come…NCT07835789

TerminatedBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesThis phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the brain (brain…NCT04789668·Houston, Texas

Enrolling by invitationIntegrated Genomics in Oncogene-driven NSCLC With Acquired ResistanceCurrently, tyrosine kinase inhibitor (TKI) remains the standard of care for oncogene-driven non-small cell lung cancer (NSCLC).NCT07122882·Taoyuan

TerminatedOral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasBackground: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Lung cancer is the leading cause of cancer-related death in the United States.NCT03233724·Bethesda, Maryland

TerminatedFDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing ChemotherapyRATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 (\^18FDG) positron emission tomography (PET)/CT scans, may help doctors predict a patient's response to treatment…NCT00424138·Los Angeles, California

RecruitingStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerThis clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy…NCT06899126·Anchorage, Alaska and 245 others

UnknownLenalidomide and Cetuximab in Patients With Advanced Solid TumorsThis is a Phase 1/2, open-label, monocentric, dose-escalation study of lenalidomide in combination with cetuximab in subjects with solid tumors.NCT01166035·Innsbruck, Tyrol

CompletedBrain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung CancerThis study is a retrospective study, screening patients with systemic PET / CT scan in our department, enrolling the ones who meet the criteria, collect their information and…NCT05380908·Zhuhai, Guangdong

PreviousPage 125 of 402Next